Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis

The rate of patients with poor indications due to non-neoplastic disease or advanced cancer is still high for both EP and TSA; multiple retreatments were necessary for EP. Although EP can be considered an appropriate primary therapy for certain ampullary adenomas, case selection for both therapies (especially with regard to the best step-up approach) should be studied further.

Authors

Institutions

Publication Details

Journal
Gut
Published
2024-12-06
DOI
https://doi.org/10.1136/gutjnl-2022-327996
Citations
15
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
4.24
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis

Thilo Hackert, Urban Arnelo, Tobias Keck, Marcus Hollenbach et al.
15 citations
Gut
Pancreatic and Hepatic Oncology Research
4.24
article

Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis

Thilo Hackert, Urban Arnelo, Tobias Keck, Marcus Hollenbach, Ana Dugic, Johanna Laukkarinen, Güralp O. Ceyhan, Laura Maggino, Christian Heise, Viliam Masaryk, Tobias Kleemann, Mário Jorge Dinis-Ribeiro, Enrique Pérez‐Cuadrado‐Robles, Edris Wedi, Steffen Muehldorfer, Fabio Casciani, Galen Leung, Tobias J. Weismüller, Fabrice Caillol, Johan Gagnière, Matthieu Bruzzi, Maria Chiara Petrone, Bertrand Napoléon, Peter Schemmer, Pierre H. Deprez, D Wichmann, Bengi Su Yilmaz, Renato Micelli Lupinacci, Arthur Berger, Charles de Ponthaud, Diogo Libânio, Mark Andrew Schattner, Piera Zaccari, Ephrem Salamé, Ana Laranjo, Bogdan Miuţescu, Yanis Dahel, William R. Jarnagin, Marco J. Bruno, Katrin Salzmann, Tiago Cúrdia Gonçalves, Andrea A. Anderloni, Brigitte Schumacher, Marco Del Chiaro, Stefano Crippa, Nicolas Musquer, Tiegong Wang, Uwe Will, Massimo Falconi, Kevin C. Soares, Asif Halimi, Giulio Belfiori, Stefano Partelli, Atsushi Oba, Régis Souche, Stéphanie Truant, Alain Sauvanet, Vasile Şandru, Alexander Waldthaler, David J. Albers, Roberto Salvia, Sébastien Gaujoux, Alessandro Zerbi, Marcel Tanțău, Sohei Satoi, Aistė Gulla, Richard D. Schulick, Sara Regnér, Steffen Seyfried, Sophia E. van der Wiel, Yosuke Inoue, Woo Hyun Paik, Louisa Bolm, Louise A. Barbier, Erik Haraldsson, Einas Abou-Ali, Gennaro Nappo, Rainer Christoph Miksch, İhsan Ekin Demir, Benjamin Meier, Reea Ahola, Elias Karam, Rita Saadeh, David Jérémie Birnbaum, Alessandro Repici, Arthur Schmidt, Marc Giovannini, Francesco Auriemma, Jean-Michel Fabre, P. David, Nicolas Régenet, Alberto Mariani, Karel Caca, J.-M. Régimbeau, Arnaud Alvès, Charles M. Vollmer, Dominik Heling, Georg Kähler, M Ilie
article en
15 citations

Abstract

The rate of patients with poor indications due to non-neoplastic disease or advanced cancer is still high for both EP and TSA; multiple retreatments were necessary for EP. Although EP can be considered an appropriate primary therapy for certain ampullary adenomas, case selection for both therapies (especially with regard to the best step-up approach) should be studied further.

GutVol. 74(3)
Université de Tours (FR), Délégation Paris 5 (FR), University of Verona (IT), Kansai Medical University (JP), Cliniques Universitaires Saint-Luc (BE), Memorial Sloan Kettering Cancer Center (US), Karolinska University Hospital (SE), Humanitas University (IT), Vita-Salute San Raffaele University (IT), Inserm (FR), University of Freiburg (DE), Carol Davila University of Medicine and Pharmacy (RO), Tampere University (FI), Vilnius University (LT), Lund University (SE), George Washington University (US), Université Clermont Auvergne (FR), Medical University of Graz (AT), Université Paris Cité (FR), Iuliu Hațieganu University of Medicine and Pharmacy (RO), Aix-Marseille Université (FR), Heidelberg University (DE), Universitätsklinikum Gießen und Marburg (DE), University Hospital Bonn (DE), Hôpital Beaujon (FR), Clinical Emergency Hospital Bucharest (RO), University Medical Center Freiburg (DE), Erasmus MC (NL), University Hospital Heidelberg (DE), TUM Klinikum (DE), Robert Bosch Hospital (DE), Seoul National University Hospital (KR), Karolinska Institutet (SE), Centre Hospitalier Universitaire de Bordeaux (FR), Centre Hospitalier Universitaire de Lille (FR), Centre Hospitalier Universitaire de Nantes (FR), Sorbonne Université (FR), Victor Babeș University of Medicine and Pharmacy Timișoara (RO), Institutul Regional de Gastroenterologie Prof. Dr. Octavian Fodor (RO), Centre Hospitalier Universitaire de Montpellier (FR), SRH Wald-Klinikum Gera (DE), Centre Hospitalier Universitaire de Tours (FR), Centre Hospitalier Universitaire Amiens-Picardie (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospital da Senhora da Oliveira Guimarães (PT), Cangzhou Central Hospital (CN), Hôpital Européen Georges-Pompidou (FR), Instituto Português de Oncologia Francisco Gentil (PT), Hôpital Européen (FR), Vivantes Klinikum (DE), IPO Porto (PT), University Hospital Schleswig-Holstein (DE), Groupe Hospitalier Diaconesses Croix Saint-Simon (FR), Institut Génétique Nantes Atlantique (FR), Pitié-Salpêtrière Hospital (FR), University Children's Hospital Tübingen (DE), Tampere University Hospital (FI), Hôpital Privé Jean Mermo (FR), Humanitas Mater Domini (IT), Tampere University (FI), The Cancer Institute Hospital (JP), Skåne University Hospital (SE), Sana Klinikum Offenbach (DE), Skaraborg Hospital (SE), Hôpital Pasteur (FR), Medizinische Universität Lausitz - Carl Thiem (DE), Klinikum Ludwigsburg (DE), Kent Hastanesi (TR), Institut Paoli-Calmettes (FR), Policlinico San Matteo Fondazione (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Générale de Santé (FR), University Medical Centre Mannheim (DE), IRCCS Humanitas Research Hospital (IT), Acıbadem Adana Hospital (TR), Unité de recherche interdisciplinaire pour la prévention et le traitement des cancers, Bosch Health Campus, University of Colorado Anschutz Medical Campus (US), Martin Luther University Halle-Wittenberg (DE), University of Göttingen (DE), University of Pennsylvania (US), Ludwig-Maximilians-Universität München (DE), Umeå University (SE), Leipzig University (DE), University of Lübeck (DE), Université de Caen Normandie (FR), University of Minho (PT)
Good health and well-being
Openalex Percentile: Top 4%
Pancreatic and Hepatic Oncology Research
4.24
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.